Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
文献类型：期刊论文
| 作者 | Yang, Rui-Xu3; Pan, Qin3; Liu, Xiao-Lin3; Zhou, Da3; Xin, Feng-Zhi3; Zhao, Ze-Hua3; Zhang, Rui-Nan3; Zeng, Jing3; Qiao, Liang4; Hu, Chun-Xiu1 |
| 刊名 | LIPIDS IN HEALTH AND DISEASE
 |
| 出版日期 | 2019-10-21 |
| 卷号 | 18期号:1页码:11 |
| 关键词 | Ceramides Autophagy High fat diet Non-alcoholic fatty liver disease |
| DOI | 10.1186/s12944-019-1118-0 |
| 通讯作者 | Fan, Jian-Gao(fanjiangao@xinhuamed.com.cn) |
| 英文摘要 | Background Ceramide plays pathogenic roles in nonalcoholic fatty liver disease (NAFLD) via multiple mechanisms, and as such inhibition of ceramide de novo synthesis in the liver may be of therapeutically beneficial in patients with NAFLD. In this study, we aimed to explore whether inhibition of ceramide signaling by myriocin is beneficial in animal model of NAFLD via regulating autophagy. Methods Sprague Dawley rats were randomly divided into three groups: standard chow (n = 10), high-fat diet (HFD) (n = 10) or HFD combined with oral administration of myriocin (0.3 mg/kg on alternate days for 8 weeks) (n = 10). Liver histology and autophagy function were measured. HepG2 cells were incubated with fatty acid with or without myriocin treatment. Lipid accumulation and autophagy markers in the HepG2 cells were analyzed. Serum ceramide changes were studied in 104 subjects consisting healthy adults, liver biopsy-proven patients with NAFLD and liver biopsy-proven patients with chronic hepatitis B (CHB). Results Myriocin reversed the elevated body weight and serum transaminases and alleviated dyslipidemia in HFD fed rats. Myriocin treatment significantly attenuated liver pathology including steatosis, lobular inflammation and ballooning. By qPCR analysis, it was revealed that myriocin corrected the expression pattern of fatty acid metabolism associated genes including Fabp1, Ppar alpha, Cpt-1 alpha and Acox-2. Further, myriocin also restored the impaired hepatic autophagy function in rats with HFD-induced NASH, and this has been verified in HepG2 cells. Among the sphingolipid species that we screened in lipidomic profiles, significantly increased ceramide was observed in NASH patients as compared to the controls and non-NASH patients, regardless of whether or not they have active CHB. Conclusions Ceramide may play an important regulatory role in the autophagy function in the pathogenesis of NASH. Hence, blockade of ceramide signaling by myriocin may be of therapeutically beneficial in NASH. |
| WOS关键词 | INSULIN-RESISTANCE ; LIVER-DISEASE ; CERAMIDE ; INHIBITION ; SPHINGOLIPIDS ; STEATOSIS ; OXIDATION ; PARADOX |
| 资助项目 | National Key Research and Development Plan 'Precision Medicine Research'[2017YFSF090203] ; National Natural Science Foundation of China[81873565] ; National Natural Science Foundation of China[81900507] |
| WOS研究方向 | Biochemistry & Molecular Biology ; Nutrition & Dietetics |
| 语种 | 英语 |
| 出版者 | BMC |
| WOS记录号 | WOS:000491351200001 |
| 资助机构 | National Key Research and Development Plan 'Precision Medicine Research' ; National Key Research and Development Plan 'Precision Medicine Research' ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Key Research and Development Plan 'Precision Medicine Research' ; National Key Research and Development Plan 'Precision Medicine Research' ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Key Research and Development Plan 'Precision Medicine Research' ; National Key Research and Development Plan 'Precision Medicine Research' ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Key Research and Development Plan 'Precision Medicine Research' ; National Key Research and Development Plan 'Precision Medicine Research' ; National Natural Science Foundation of China ; National Natural Science Foundation of China |
| 源URL | [http://cas-ir.dicp.ac.cn/handle/321008/172403]  |
| 专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
| 通讯作者 | Fan, Jian-Gao |
| 作者单位 | 1.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China 2.Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China 3.Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Ctr Fatty Liver,Dept Gastroenterol, Shanghai 200092, Peoples R China 4.Univ Sydney, Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW 2145, Australia |
| 推荐引用方式 GB/T 7714 | Yang, Rui-Xu,Pan, Qin,Liu, Xiao-Lin,et al. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis[J]. LIPIDS IN HEALTH AND DISEASE,2019,18(1):11. |
| APA | Yang, Rui-Xu.,Pan, Qin.,Liu, Xiao-Lin.,Zhou, Da.,Xin, Feng-Zhi.,...&Fan, Jian-Gao.(2019).Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.LIPIDS IN HEALTH AND DISEASE,18(1),11. |
| MLA | Yang, Rui-Xu,et al."Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis".LIPIDS IN HEALTH AND DISEASE 18.1(2019):11. |
入库方式： OAI收割
来源：大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。